Cohorts of Prkar1a+/−, Prkar2a+/−, Prkar2a−/−, Prkar2b+/− and wild type (WT) mice have been observed between 5 and 25 months of age for the development of hematologic malignancies. This evidence concerns the gene PRKAR2A and hematologic disorder.